Prellis Biologics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
953 Indiana St, San Francisco, Californi...Phone Number
(415) 742-1283Website
www.prellisbio.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
3
1
1
1
About Prellis Biologics
Founded in 2016 and headquartered in San Francisco, United States, Prellis Biologics is a company developing the tools to create 3D-printed organs.Explore more
Prellis Biologics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prellis Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Prellis Biologics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Prellis Biologics launches new products
Check out if Prellis Biologics is spiking on competitors!
Click to see if Prellis Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Prellis Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Prellis Biologics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Prellis Biologics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Prellis Biologics has new funding data
Recommended Actions
Reach out to Masked Content who joined Prellis Biologics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Prellis Biologics
Compare insights from companies similar to Prellis Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Prellis Biologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Prellis Biologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Prellis Biologics.
Prellis Biologics financials insights
Gather financial insights about Prellis Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Other Financing Round
$120K
Series A
$1.8M
2021
Series B
$14.5M
2022
Series C
$35M
Prellis Biologics Tech Stack
A closer look at the technologies used by Prellis Biologics
Most Recent Scoops
Open Position
Hiring Plans
Prellis Biologics has more open roles in Finance than it has had at any time in the past 12 months. Technologies mentioned include: Berkeley Payment Solutions.
Hiring Plans
Hiring Plans
Prellis Biologics has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Prellis Biologics has more open roles in Information Technology than it has had at any time in the past 12 months. Technologies mentioned include: Python, AWS Identity and Access Management, Amazon AWS, PostgreSQL, SQL, Google Analytics, and Amazon Relational Database Service.
Hiring Plans
Open Position
Prellis Biologics News & Media
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
SAN FRANCISCO--(BUSINESS WIRE)--Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from Khosla Ventures, SOSV, True Ventures, and Lucas Venture Group. Dr. Nohaile joins from Generate Biomedicines and succeeds Prellis Bio founder Dr. Melanie Matheu, who will assume the role of Chief Technology OfficerPrellis Biologics Announces Collaboration with Sanofi
SAN FRANCISCO--(BUSINESS WIRE)-- #Agreement--Prellis Biologics has entered into a collaboration and license option agreement with Sanofi.Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb
SAN FRANCISCO--(BUSINESS WIRE)-- #BMS--Prellis Biologics announced a multi-target drug discovery collaboration and license agreement with Bristol Myers Squibb.Prellis Biologics raises $14.5M, debuts a "human immune system" in a dish
Prellis Biologics, a company developing the tools to create 3D printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Prellis Biologics
Sign Up For FreeTo access detailed company insights
Founded in 2016 and headquartered in San Francisco, United States, Prellis Biologics is a company developing the tools to create 3D-printed organs.... Read More
